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Previewsearlier mortality, had higher levels of
inflammatory cytokines in the serum, and
contained increased number of bacteria
in the peritoneum. In humans it has been
noted that septic shock patients have an
increased risk of mortality in the early
morning, suggesting a circadian clock-
dependent response. However, sepsis in
general is not strictly TLR9 dependent
and other TLRs such as TLR2 and TLR4
are important players in gram+ and gram
bacteria-mediated septic shock. There-
fore, apart from TLR9, other PRRs prob-
ably are also under circadian control and
influence immune reactions in a circadian
rhythm-dependent manner.
However, in TLR9-driven autoimmune
diseases such as SLE a possible correla-
tion between oscillating TLR9 expressionand severity of disease could help to opti-
mize the therapeutic efficiencyof immuno-
modulatory reagents such as TLR9 inhibi-
tory ODNs.
Overall, this study has important impli-
cations for TLR9-driven immunotherapy
and will further nourish the research on
the influence of the circadian clock on im-
mune responses and immune
intervention.
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Regulatory T (Treg) cells are thought to be susceptible to conversion into effector T cells. In this issue of
Immunity, Miyao et al. (2012) provide evidence that the apparent plasticity of murine Foxp3+ Treg cells is
largely restricted to a defined subset of poorly committed Foxp3+ cells.Proper functioning of the immune system
implies a tightly balanced regulation of
effector mechanisms to avoid autoimmu-
nity and immunopathology. A variety of
control mechanisms have been identified,
comprising negative feedback circuits
affecting activation, survival, or functioning
of effector cells. Regarding the discrimina-
tion of self from non-self, central tolerance
was initially thought to be the key in avoid-
ing autoimmunity, but the (re)discovery of
specific T cells populations, now called
regulatory T (Treg) cells, that can suppress
self-reactive responses and that are char-
acterized by the expression of the tran-
scription factor Foxp3has led to the insight
that dominant tolerance mediated by
Foxp3+CD4+ Treg cells is a vital compo-
nent of the immunological balance.
Not surprisingly, this population of
Foxp3+ Tcells hasattractedmuch interest,including that of clinical scientists consid-
ering transfer of Treg cells as a valuable
therapy to control life-threatening graft-
versus-host disease, to improve accep-
tance of transplanted organs, or to
suppress autoimmunity in a more specific
way than by currently used therapies.
However, such therapies would encounter
unpredictable risks if the cell type trans-
ferred would be unstable or even could
convert into effector cells producing
inflammatory cytokines, as some recent
experimental data suggested. The ques-
tion of whether Foxp3+ Treg cells repre-
sent a stable lineage or display a substan-
tial degreeof plasticity is therefore amatter
of considerable importance, particularly
because previous investigations resulted
in controversial conclusions.
What is the evidence that Foxp3+ Treg
cells are defined lineages? No doubt thatT cells of a number of functional states
can have suppressive actions. IL-10-
producing CD4+ T cells, for example,
clearly have an important regulatory func-
tion, but so far evidence is rather pointing
to contextual acquisition of this property,
optional both for cells of the Treg cell
lineage as well as for multiple inflamma-
tory phenotypes such as Th1, Th2, or
Th17 cells. IL-10-producing cells lack a
clonal commitment to produce IL-10 and
apparently do not establish an IL-10-
specific cytokine memory; i.e., these cells
do not fulfill the definitions of a stable cell
lineage (Dong et al., 2007).
The situation seemed to be different for
Foxp3+ Treg cells, which is believed to de-
velop autonomously as a separate lineage
within the thymus and to harbor a high
degree of stability both in vitro and in vivo.
However, upon the emergence of moreFebruary 24, 2012 ª2012 Elsevier Inc. 161
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Previewsand more studies providing evidence that
Foxp3+ cells could give rise to Foxp3
and even effector cytokine+ progeny,
especially in an inflammatory environ-
ment, the possibility had to be considered
that also Foxp3+ Treg cells could show
plasticity and become inactivated or
even converted into effector cells.
The straightforward approach to clarify
the issue of plasticity appears to be sort-
ing to highest possible purity and moni-
toring the stability of Foxp3 expression,
suppressive properties, and methylation
status of an evolutionary conserved el-
ement within the Foxp3 locus (TSDR,
Treg cell-specific demethylated region)
as marker for a stable Treg cell phenotype
during in vitro or in vivo expansion. But
how can we determine purity if an
unequivocal marker for Treg cells does
not exist? Studies aiming at expanding
Treg cells for application in graft-versus-
host disease have observed striking
differences in the apparent stability of
Foxp3+ cells during in vitro expansion, de-
pending upon the marker combination
used for sorting (Hoffmann et al., 2009);
this can be interpreted as a different
degree of plasticity among Treg cell
subsets or, alternatively, as an outgrowth
of a minor subset of cells not completely
committed to a stable Treg cell lineage.
Outgrowth, but not heterogeneity, of the
starting population could be excluded in
the above-mentioned study by cloning;
yet still loss of Foxp3 expression is not
necessarily indicative of loss of Treg cell
identity.
Indeed, the question of whether Foxp3
expression is sufficient to define Treg cell
identity is not trivial. Although a number
of investigations have underlined the
central importance of Foxp3 expression
for the suppressive program, the notion
that Foxp3 is the master transcription
factor of Treg cells is probably a (popular)
oversimplification. Notably in the human
system, Foxp3 expression without the
acquisition of suppressive activity is
routinely observed upon activation of
CD4+ T cells. But even in the murine
system, where Foxp3 expression appears
to be more restricted, several studies
provide evidence that commitment to the
Treg cell lineage occurs before induction
of and might actually be independent of
Foxp3 expression. Moreover, the unique
transcriptome of Treg cells can only partly
be explained by the impact of Foxp3 on162 Immunity 36, February 24, 2012 ª2012 Egene activity (Hill et al., 2007), and com-
mitted Foxp3 Treg cell precursors prone
to upregulate Foxp3 expression can be
identified in both thymic and peripheral
subpopulations of CD25+Foxp3CD4+
T cells (Lio and Hsieh, 2008; Schallenberg
et al., 2010).
The study of Miyao et al. (2012) in this
issue of Immunity provides compelling
evidence that in the murine system,
Foxp3 expression is also more promis-
cuous and not completely indicative of
a stable Treg cell lineage. By using a
Foxp3-driven, Cre-mediated fate map-
ping approach that permanently marks
all cells that had expressed Foxp3 at any
time during their development, the
authors could demonstrate that a sizeable
fraction of cells can be detected that had
only transiently expressed Foxp3 but
later, as ‘‘exFoxp3’’ cells, can easily
convert into effector cells under appro-
priate conditions, whereas a core popula-
tion of committed Foxp3+ Treg cells exists
that are stable and resistant to conversion
into effector cells.
Similar systems have been used previ-
ously but led to contrasting conclusions.
In a BAC transgene-based system, a
considerable emergence of exFoxp3
cells, especially under inflammatory con-
ditions, has been observed, which was
paralleled by the occurrence of cyto-
kine-producing effector cells among
them. This led to the authors’ conclusion
that at least a subset of Foxp3+ Treg
cells displays plasticity and can be con-
verted into effector T cells (Zhou et al.,
2009). In contrast, an inducible system
allowing snapshot labeling of Foxp3+
Treg cells during a defined time window
did not reveal a major fraction of cells
losing Foxp3 in adult mice. However, a
minor fraction of exFoxp3 cells was
also reported in this study (Rubtsov
et al., 2010).
Miyao et al. (2012) now provide a frame-
work of findings reconciling these data by
showing that (1) ‘‘exFoxp3’’ cells repre-
sent a small but significant fraction of
T cells in the adult that develop predomi-
nantly during early periods of life and
along conversion of naive cells into (adap-
tive) Treg cells in the periphery under
homeostatic conditions; (2) cells tran-
siently expressing Foxp3 have a higher
potential to expand than ‘‘true’’ Treg cells,
especially under lymphopenic (IL-2-defi-
cient) conditions; (3) amajority of exFoxp3lsevier Inc.cells represents conventional T cells by
phenotype, differentiation potential, and
methylation status in the stability-deter-
mining TSDR of the foxp3 locus; and (4)
a minority of exFoxp3 cells are committed
Treg cells displaying transient downregu-
lation of Foxp3 expression because of
lack of appropriate T cell receptor (TCR)
and/or IL-2 signaling while maintaining
the demethylated TSDR status and
rapidly reacquiring Foxp3 expression
upon TCR stimulation (Figure 1).
Thus, apparent plasticity of Foxp3+
Treg cells might largely be explained by
heterogeneity of Foxp3-expressing cells.
The use of single-cell assays, such as
limiting-dilution approaches, seems at-
tractive to further prove this assumption,
yet might be difficult in the murine system
because of the poor proliferation capacity
of Treg cells.
That dissociation between Foxp3
expression and those features defining
a committed Treg cell lineage occurs
more frequently among Foxp3+ cells
induced in the periphery suggests that
environmental conditions for the im-
printing of a stable Treg cell lineage are
favorable within the thymus. In contrast,
peripherally induced Foxp3+ T cells dis-
play a whole spectrum of properties,
from transient, functionally irrelevant
Foxp3 expression via unstable Treg cells
without epigenetic fixation (as in TGF-
b-induced Treg cells) to fully stable Treg
cells with demethylated TSDR induced
by tolerogenic DEC205 vaccination (Po-
lansky et al., 2008). These differences
might especially be relevant for the gut
mucosa as a dominant site of peripheral
Treg cell induction.
One key question remains to be
answered: what are the signals that lead
to the imprinting of a stable Treg cell
phenotype? A variety of factors including
TCR activation, CD28 costimulation, and
IL-2 signaling have been suggested to
contribute to the differentiation into Treg
cells; however, the precise nature of
signals leading to the selective demethy-
lation of the Foxp3 locus are only incom-
pletely understood (Klein and Jovanovic,
2011). Presently it is absolutely open
whether specific second signals are
instrumental or whether the decision
between Treg cell commitment and differ-
entiation into conventional T cells is a
matter of defined signal strengths of the
TCR in conjunction with supporting as
Figure 1. Commitment and Differentiation of Foxp3+ Treg Cells
Differentiation of Treg cells along distinct pathways might be associated with a differential degree of
commitment. Thymic development appears to be characterized by early commitment, even before
expression of Foxp3, and preferential adoption of a stable phenotype that is imprinted by CpG demethy-
lation in the TSDR (CNS2). Differentiation of Foxp3+ cells in the periphery includes a larger proportion of
‘‘promiscuous Foxp3+’’ cells that upregulate Foxp3without acquisition of a stable suppressive phenotype,
giving rise to both ‘‘exFoxp3’’ cells convertible into effector cells as well as to stable, peripherally induced
Treg cells.
Immunity
Previewswell as counteracting environmental
signals and cell-intrinsic developmental
predispositions.
Answering of these questions will not
only be of central importance for theunderstanding of the origin of the Treg
cell lineage, but also better define the
conditions to be met when induction or
expansion of Foxp3+ Treg cells for thera-
peutic application is intended.Immunity 36,REFERENCES
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In this issue of Immunity, den Braber et al. (2012) highlight differences in naive T cell lifespan between mice
and humans. Their data suggest that mechanisms of naive T cell maintenance may differ between mice and
men.How long do naive T cells live and how are
they replenished? A short life span for
naive T cells would necessitate faster
rates of replenishment, whereas in-
creased life span would accommodateslower rates of replenishment. Work in
this issue of Immunity by den Braber
et al. (2012) examines the longevity of
naive T cells. Their data suggest that
mechanisms maintaining T cells withnaive phenotypes might differ in humans
and mice (den Braber et al., 2012).
The life span of mice is 2 years,
whereas humans live much longer. Do
the naive T cells of mice and humansFebruary 24, 2012 ª2012 Elsevier Inc. 163
